A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
Drug/radiation resistance to treatment and tumor relapse are major obstacles in identifying a cure for cancer. Development of novel agents that address these challenges would therefore be of the upmost importance in the fight against cancer. In this regard, studies show that the antiapoptotic protei...
Main Authors: | Xiang Ling, Shousong Cao, Qiuying Cheng, James T Keefe, Youcef M Rustum, Fengzhi Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3446924?pdf=render |
Similar Items
-
Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation
by: Dowling Catherine, et al.
Published: (2009-06-01) -
Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer
by: Sreevidya Santha, et al.
Published: (2020-11-01) -
The studies on the cIAP1-associated proteins and cIAP1 ubiquitination
by: Yung-Fu Chang, et al.
Published: (2006) -
Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation
by: Jieqiong Zhang, et al.
Published: (2019-05-01) -
Expression and Correlation of Cell-Free cIAP-1 and cIAP-2 mRNA in Breast Cancer Patients: A Study from India
by: Amit Kumar Verma, et al.
Published: (2020-01-01)